Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Yanhong Deng, MD) · 13925106525@163.com · 008613925106525

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Induction Chemotherapy for Locally Recurrent Rectal Cancer

Recurrent Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Ghent, Belgium · Amsterdam, Netherlands

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Metastatic Colorectal Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Kingman, United States · Phoenix, United States

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Colorectal Cancer · Liver Metastases

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Guangzhou, China · Hangzhou, China